Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!

Por Russo, Margherita, Rifici, Carmela, Sessa, Edoardo, D’Aleo, Giangaetano, Bramanti, Placido, Calabrò, Rocco Salvatore
Publicado no Daru (2015)

Impact of Depression, Fatigue, and Global Measure of Cortical Volume on Cognitive Impairment in Multiple Sclerosis

Por Nunnari, Domenica, De Cola, Maria Cristina, D'Aleo, Giangaetano, Rifici, Carmela, Russo, Margherita, Sessa, Edoardo, Bramanti, Placido, Marino, Silvia
Publicado no Biomed Res Int (2015)

Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation

Por Russo, Margherita, Calabrò, Rocco Salvatore, Naro, Antonino, Sessa, Edoardo, Rifici, Carmela, D'Aleo, Giangaetano, Leo, Antonino, De Luca, Rosaria, Quartarone, Angelo, Bramanti, Placido
Publicado no Neural Plast (2015)

The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology

Por Russo, Margherita, Dattola, Vincenzo, Logiudice, Anna Lisa, Ciurleo, Rosella, Sessa, Edoardo, De Luca, Rosaria, Bramanti, Placido, Bramanti, Alessia, Naro, Antonino, Calabrò, Rocco Salvatore
Publicado no Medicine (Baltimore) (2017)

Relationship between Interferon Beta-1A Administration and Intracranial Vascular Tone Regulation in Patients with Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Por Dattola, Vincenzo, Bonanno, Lilla, Naro, Antonino, Chillura, Antonino, Logiudice, Anna Lisa, Sessa, Edoardo, Famà, Fausto, Quartarone, Angelo, Calabrò, Rocco Salvatore, Marino, Silvia, Russo, Margherita
Publicado no Biomed Res Int (2017)

Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study

Por Ciurleo, Rosella, Bonanno, Lilla, De Salvo, Simona, Romeo, Laura, Rifici, Carmela, Sessa, Edoardo, D’Aleo, Giangaetano, Russo, Margherita, Bramanti, Placido, Marino, Silvia, Caminiti, Fabrizia
Publicado no PLoS One (2018)

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients

Por Durastanti, Valentina, Lugaresi, Alessandra, Bramanti, Placido, Amato, Mariapia, Bellantonio, Paolo, De Luca, Giovanna, Picconi, Orietta, Fantozzi, Roberta, Locatelli, Laura, Solda', Annalisa, Sessa, Edoardo, Totaro, Rocco, Marino, Silvia, Zipoli, Valentina, Zorzon, Marino, Millefiorini, Enrico
Publicado em 2011

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)

Por Messina, Silvia, Solaro, Claudio, Righini, Isabella, Bergamaschi, Roberto, Bonavita, Simona, Bossio, Roberto Bruno, Brescia Morra, Vincenzo, Costantino, Gianfranco, Cavalla, Paola, Centonze, Diego, Comi, Giancarlo, Cottone, Salvatore, Danni, Maura Chiara, Francia, Ada, Gajofatto, Alberto, Gasperini, Claudio, Zaffaroni, Mauro, Petrucci, Loredana, Signoriello, Elisabetta, Maniscalco, Giorgia Teresa, Spinicci, Gabriella, Matta, Manuela, Mirabella, Massimiliano, Pedà, Graziella, Castelli, Letizia, Rovaris, Marco, Sessa, Edoardo, Spitaleri, Daniele, Paolicelli, Damiano, Granata, Alfredo, Zappia, Mario, Patti, Francesco
Publicado no PLoS One (2017)